<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Riaz S</submitter><funding>Norges Forskningsråd</funding><funding>Universitetet i Bergen</funding><funding>Innovationsfonden</funding><pubmed_abstract>Efforts to develop broadly protective vaccines against pathogenic &lt;i>Escherichia coli&lt;/i> are ongoing. A potential antigen candidate for vaccine development is the metalloprotease YghJ, or SslE. YghJ is a conserved mucinase that is immunogenic, heavily glycosylated, and produced by most pathogenic &lt;i>E. coli&lt;/i>. To develop efficacious YghJ-based vaccines, there is a need to investigate to what extent potentially protective antibody responses target glycosylated epitopes in YghJ and to describe variations in the quality of YghJ glycosylation in the &lt;i>E. coli&lt;/i> population. In this study we estimated the proportion of anti-YghJ IgA antibodies that targeted glycosylated epitopes in serum and intestinal lavage samples from 21 volunteers experimentally infected with wild-type enterotoxigenic</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>760135</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8718676</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Characterization of Glycosylation-Specific Systemic and Mucosal IgA Antibody Responses to &lt;i>Escherichia coli&lt;/i> Mucinase YghJ (SslE).</pubmed_title><pmcid>PMC8718676</pmcid><pubmed_authors>Riaz S</pubmed_authors><pubmed_authors>Thorsing M</pubmed_authors><pubmed_authors>Steinsland H</pubmed_authors><pubmed_authors>Andersen AZ</pubmed_authors><pubmed_authors>Hanevik K</pubmed_authors><pubmed_authors>Boysen A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterization of Glycosylation-Specific Systemic and Mucosal IgA Antibody Responses to &lt;i>Escherichia coli&lt;/i> Mucinase YghJ (SslE).</name><description>Efforts to develop broadly protective vaccines against pathogenic &lt;i>Escherichia coli&lt;/i> are ongoing. A potential antigen candidate for vaccine development is the metalloprotease YghJ, or SslE. YghJ is a conserved mucinase that is immunogenic, heavily glycosylated, and produced by most pathogenic &lt;i>E. coli&lt;/i>. To develop efficacious YghJ-based vaccines, there is a need to investigate to what extent potentially protective antibody responses target glycosylated epitopes in YghJ and to describe variations in the quality of YghJ glycosylation in the &lt;i>E. coli&lt;/i> population. In this study we estimated the proportion of anti-YghJ IgA antibodies that targeted glycosylated epitopes in serum and intestinal lavage samples from 21 volunteers experimentally infected with wild-type enterotoxigenic</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-07-16T15:33:51.678Z</modification><creation>2022-02-11T14:49:38.865Z</creation></dates><accession>S-EPMC8718676</accession><cross_references><pubmed>34975849</pubmed><doi>10.3389/fimmu.2021.760135</doi></cross_references></HashMap>